General Information of Drug (ID: DMSDGEJ)

Drug Name
OP0201
Indication
Disease Entry ICD 11 Status REF
Acute otitis media AB00 Phase 2 [1]
Cross-matching ID
TTD ID
DT30ZG

References

1 ClinicalTrials.gov (NCT03818815) A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months. U.S.National Institutes of Health.